Overview of the Company

Alkem Laboratories Ltd. was founded in 1974 with a dream to improve the quality of
life with exceptional healthcare facilities and services.
Alkem, a leading generic and specialty drug manufacturer, is Indias seventh largest
pharmaceutical company with sales revenues exceeding USD 500 million, with a
CAGR of 16% over the last 5 years.
Alkem is a pioneer in the acute and chronic therapeutic segments with extensive
brand share in the Central Nervous System, Gastro-intestinal, Anti-diabetic, Antimalarial, Cardiovascular, Immunosuppressants, and Neutraceuticals segments.
Alkems success is highlighted by its leadership in the Anti-infective and Pain
Management segments. Of its portfolio of 800 brands, 3 brands, Taxim (Cefotaxim),
Clavam (Amoxicillin + Clavulanic Acid), and Sumo (Paracetamol) are ranked among
the top 25 brands in India, while 14 feature among the top 300 brands in the Indian
market.

Alkems state-of-the-art manufacturing facilities across 7 locations in India,

approved by global regulatory authorities including the US FDA, UK MHRA, MCC
South Africa, evidences Alkems capabilities in offering quality generic and branded
products in over 48 countries across the globe.
Over the past three and a half decades while being constantly fuelled with
dedication and passion, Alkem has become known the world over as a premiere
healthcare institution in generics and branded formulations.

Today, it covers both acute and chronic therapeutic segments with a diverse product
portfolio in every possible segment of the pharmaceuticals industry. Currently, its
products are marketed in 35 countries worldwide, with many more following soon.

Alkems strength lies in its ability to manufacture innovative products and envision
business potential in various segments, most recently, the health food market. The
range of products in this segment would largely be based on a wide range of
applications of FOS and Sucralose, a natural sweet tasting and sugar free, low
calorie sweetener. Moving ahead in this endeavour, Alkem has recently set up the
worlds largest Sucralose producing unit in India.

Headquartered in Mumbai, Alkem is the 7th largest Pharmaceutical and Healthcare

Company in the Indian Pharmaceutical Industry with sales revenues exceeding $350

million and a healthy annual growth of over 20%. Over the past decade it has been
on an accelerated growth path in an increasingly competitive environment not just
in domestic markets but also in international markets.

Some of the highlights of Alkem Labs:

Alkem is a leader in the Antiinfective segment and Ranks No. 1 in the

Cephalosporins market in India.
Alkem is also counted amongst the leaders in the Gastroenterology, Pain
Management and Antiosteoporosis market.
Alkem's sales, marketing strengths and expertise in brand building are widely
recognised as the best with 2 brands amongst the top 25 brands & 11 brands
amongst the top 300 brands of the country. Alkem has 28 brands with sales of over
$2 million.
Alkems world class in-house manufacturing capabilities, spread across 7
manufacturing facilities in the country has played a vital role in its success in the
domestic and the international markets.
Alkem is rapidly making strides in the global Pharmaceutical market with footprints
in more than 35 countries.
Alkem has filed 15 ANDAs and has an approval of 5 products in the US market.
Several products are in the pipeline for the US, European and Asian markets.

Our Vision

To achieve value driven leadership through...

-

Quality thats infinite

Service thats caring

Hardwork thats enduring

In India, we are collaborating our combined efforts to regain and surge to the
coveted top 5 pharmaceutical companies by 2012. We wish to achieve this
milestone through organic growth and inorganically through international
partnerships and strategic alliances that would enhance our reach globally.

Our Mission

Alkem is collaborating its combined efforts to get in the coveted top 5

pharmaceutical companies of India by 2012. Alkem wishes to achieve this milestone
through organic growth as well as its affiliations with international associations,
partnerships and strategic alliances.

Our Values

Alkem - Healthcare beyond boundaries

At Alkem, we genuinely believe that quality Healthcare services have no

boundaries. Moving forward in this direction, we stretch our imagination and
resources to deliver the best Healthcare available in the medical field today.
Moreover, our People-First Policy ensures that we not just meet the ever growing
customer expectations, but surpass them in every possible way we can.

At Alkem, 3 vital elements have helped us build our reputation:

Curiosity: We encourage our team not to be content with what they are told, but
rather go out there and learn & study the topic even further. This approach helps
the individual grow and take Healthcare to higher levels.

Passion: The constant burst of enthusiasm that propels an individual to complete a

given task also enables other team members to contribute significantly.

Accountability: While Curiosity and Passion pushes us into unexplored Healthcare

spaces, Accountability ensures that we focus our complete attention in seeing
things from the ideation stage right until the implementation stage.

Overall Strategy

Augmentation of product portfolio: Our quest for new products and concepts never
ends. We intend to further enhance our product portfolio across various therapy
areas in the Acute and Chronic segments.

Acute portfolio and Chronic portfolio: We currently enjoy a dominant position in the
Acute portfolio segment. Moving ahead in this segment, we plan to consolidate our
Acute portfolio and further tighten our hold in the market. Simultaneously, we are
concentrating our combined efforts to build our Chronic Portfolio. Overall, we intend
to create a good balance of Acute and Chronic driven therapy areas.

Customer expansion/penetration: Customer expansion in terms of the target

audience and Customer penetration in terms of the reach is an important strategic
focus for us in the coming years in both domestic and International markets.

Continue focus on Brand Building: Brands are the strongest representator of our
company and Brand building is a critical success factor in todays competitive
scenario. We at Alkem have always understood this crucial business need and have
worked towards building the most envious brands in the Indian Pharmaceutical
industry. Today Alkem has almost 11 brands in the list of top 300 best selling
products of the industry. We also have over 28 brands worth more than $ 2 million
in our product portfolio.

Build In-licensing and strategic alliances: We encourage marketing partnerships and

product acquisition opportunities in all the markets where we operate. Alkem

continues to explore market opportunities through Licensing and Alliances to draw

maximum value from such arrangements. We continuously evaluate strategic
opportunities to enhance our presence in various therapy areas.

For marketing alliances we work on non-infringement policies and completely

respect intellectual property rights of our partners.

Some of the successful partnerships of Alkem include:

Karo Bio

Sweden

Gnosis

Switzerland

Oculus

The Netherlands

Reyon -

South Korea

Cargen

South Korea

Oculus Innovative Science

Hor Phag

USA

Switzerland

Product Profile
11 of our brands are listed in the top 300 brands in India, as per June 2011 IMS. We are rated as the
No.2 Company in the overall Antibacterial Segment and No.1 in Cephalosporin Formulations. We also
have a significant presence in several other therapy areas including Gastroenterology, Orthopaedics,
Oncology, Neuropsychiatry, Cardiovascular and Gynaecology, to mention a few. As a matter of fact, in
several of these segments, Alkem is considered to be a leader.
SBUs (Strategic Business Units)
At Alkem our domestic business is modelled through a strong and established therapy focused
Strategic Business Units (SBU's)
The following gives the therapy focus of the respective SBU's
Therapy focused SBU's

Main (Alkem I/II)

Ulticare

Bergen

Anti-infective

Antiinfective

Anti-infective

Pain Management &

Gastro Division

&

Bone Health
Division

Alkem
Pharma

Extra Urban
Division

Pentacare Neuroscience
Advanced
Neurology

Neurology

Respiratory
Division

Bergen Zurieve

Derma Care

Mediva

Gynecology and
Infertility

Dermatology Cardiology &

Diabetology

Cytomed

Oncology
Division

Aliva

Futura

Generic Division

Whilst in branded generics the Main Pharma Division, Ulticare and Bergen are the primary revenue
generators, the newer specialty divisions, Pentacare, Neurosciences (Neuropsychiatry), Mediva (Cardio
- Diabeto), Cytomed (Oncology) and Dermacare (Dermatology) are growing rapidly and are enhancing
their market share in the chronic segment space with a wide range of products in their respective
categories.
A substantial share in the generics business with two divisions catering (Alive/Futura) exclusively to the
generic business.
Alkem Pharma division is Alkems endeavour to venture in to the potential extra-urban space existing
in the Indian Pharma market.
Alkems offerings can be categorized as:
1) ACTIVE PHARMACEUTICAL INGREDIENT (API)
2) GENERIC PRODUCTS
3) BRANDED PRODUCTS
Alkems branded products enable people to lead a better quality of life. Alkems specialized
facilities and scientific resources help develop and manufacture products that are tailored to
address patient needs. As the branded business grows, Alkem continues to explore new areas
and exit platforms, in pursuit of enabling people live better lives.
Alkems stringent adherence to quality, coupled with its extensive marketing reach, has
enabled some of its brands to emerge as top brands in their respective segments. Today,
Alkem has over 800 branded products available across India.
Alkems brands lead in the Anti-infective, Gastro and Pain Management therapeutic areas, with
14 of them being ranked among the top 300 Indian brands.

Brand name

Therapeutic segment

"Anti-infective"

"Gastro"

"Gastro"

"Pain"

"Anti-infective"

4) NUTRACEUTICALS

Alkem Healthcare, a subsidiary of Alkem, offers a wide range of nutraceuticals a series of pharmabased nutritional food products. With the focus on providing solutions for Obesity, Diabetes, Cardiac &
Neurological problems, Alkem Healthcare endeavours to provide wholesome and functional health care
solutions, that are convenient to use and flavourful.
Alkem currently manufactures two sugar substitutes: Sucralose, which is a zero calorie sweetener;
and Fructo Oligosaccharide (FOS), which is a natural sweetener with prebiotic properties. FOS is also
approved as a soluble fibre neutraceutical which helps lowering LDL cholesterol levels to promote
cardiovascular health along with boosting immunity. For Sucralose, Alkem has developed a cost
effective, environment friendly, patent non-infringing process which conforms to USP-NF specifications
and is certified by the CFTRI & BAJAJ centre.
Nutraceuticals manufactured by Alkem include:

Jeevanprash
Jeevanprash is a sugar less, fat free natural food supplement. Jeevanprash contains FOS, instead of
sugar, while offering the same sweet taste; additionally, it contains 36 natural ingredients to improve

immunity, strength, stamina, vigour, and rejuvenation. Jeevanprash is also an excellent anti-ageing
tonic.
Jeevanprash is a good antioxidant that rids the body of toxins consumed every day through foods and
pollutants.

Blo-Cal- Liquid Drops

Blo-Cal is a no-calorie sweetener which has Sucralose, an internationally acclaimed zero calorie
sweetener. Blo-Cal is India's first Sucralose based liquid sweetener. Blo-Cal is 600 times sweeter than
sugar; thus, a drop of Blo-Cal is good enough to give sweetness equivalent to a tea spoon of sugar.
Blo-Cal is ideal for the calorie & weight conscious, the obese and the diabetic. It is safe, healthy and
approved by the World Health Organisation (WHO) & US FDA, among others.

Natura Tammy: Low Calorie Healthy Jelly

Natura Tammy is a low calorie healthy jelly enriched with:

Brahm & Shankhpushpi: Improves concentration, memory & learning abilities

Aloe Vera: Helps improve immunity, digestion and aids detoxification

Natura Tammy Jelly is also rich in Fructo-Oligosaccharide (FOS), a dietary fibre with prebiotic
properties. Currently available in delicious orange, mango, strawberry & guava flavours, Natura
Tammy will soon be available in new attractive 10, 25 & 100 unit consumer packs.

Fizzo
A Sucralose based antacid. It offers relief from symptoms of gas, indigestion & acidity, within seconds.

LEARNING EXPERIENCE
Stage 1: decartoning process

This process included checking of defects in vials manually after removal

from cartons.

Stage 2: vial washing

This process includes washing of vials in purified water.
This washing was done in 10 cycles in 1 min in total.
The basic purpose is to remove bio particles.
The speed of machines is 180 miles per minute
Stage3: Tunnel
At this stage exogenous toxic are killed at 330 degree Celsius.
This process takes 3 min in total

Stage4 : Filling and bunging machine

This stage involves pulling rubber is put on vial
The main job here is to fill main drug in the vial.
Mainly 220 bottles are filled per minute
Stage5: Flip of seal cap
120 mg of drugs is filled up in vial
Stage6: Inspection
The final defects are checked including the weight of drugs in vial and
cleanliness .
2 percent defects are acceptable and beyond this are kept in rejection list
The entire process of as in all six stages takes one hour.